Skip to main content

Table 2 Neuroimaging

From: 18F-florbetaben Aβ imaging in mild cognitive impairment

     MCI subtype   
  HC ( n = 15) AD ( n = 15) All MCI ( n = 45) naMCI ( n = 4) asMCI ( n = 12) amMCI ( n = 29)
Neocortical SUVR 1.26 ± 0.22 1.96 ± 0.27 1.54 ± 0.27AB 1.50 ± 0.35B 1.66 ± 0.20AB 1.49 ± 0.28B
High β-amyloid, n (%) 3 (20) 15 (100) 24 (53)B 1 (25)B 10 (83)AC 13 (45)B
Hippocampal volume (cm3)    7.1 ± 0.9 7.1 ± 0.8 7.0 ± 0.8 7.2 ± 1.0
WMH volume (cm3)    10.2 ± 11.0 13.3 ± 15.5 4.8 ± 6.6C 12.0 ± 11.4
  1. AD, Alzheimer's disease; amMCI, amnestic multidomain mild cognitive impairment; asMCI, amnestic single-domain mild cognitive impairment; HC, healthy older controls; MCI, mild cognitive impairment; naMCI, nonamnestic mild cognitive impairment; SUVR, standard uptake value ratio; WMH, white matter hyperintensities. AP < 0.05, MCI subtype compared with HC. BP < 0.05, MCI subtype compared with AD. CP < 0.05, asMCI compared with amMCI.